ChatGPT Image Aug 5, 2026, 03_58_45 PM (1)
previous arrow
next arrow
ChatGPT Image Aug 5, 2026, 03_58_45 PM (1)
ChatGPT Image Aug 5, 2026, 02_25_46 AM (1)
ChatGPT Image Aug 5, 2026, 02_27_28 AM (1)
previous arrow
next arrow
DIVAS PHARMA LTD

DIVAS PHARMA LTD is positioned as a London-registered pharmaceutical, scientific, engineering and technology company with the potential to connect healthcare priorities with disciplined technical delivery. Its registered business classifications provide a broad platform: pharmaceutical preparations form the central sector identity, while technology services, engineering consultancy and wider scientific activities create room for an integrated operating model. That combination can support a company narrative built around quality, practical innovation, responsible collaboration and reliable execution.

The company’s proposed purpose is straightforward: to apply science, technology and professional expertise in ways that can support better, safer and more dependable healthcare outcomes. This purpose does not require exaggerated claims. It can be communicated through careful commitments: understand stakeholder needs, define requirements clearly, work within the applicable legal framework, build quality into every process, protect the integrity of data, manage risk transparently and improve through evidence. For a pharmaceutical business, trust grows from the quality of decisions and records as much as from the quality of the final output.

We offer a wide range of Pharma Products

Capsules -
ALMOL 500 – Paracetamol 500 mg
CEFIXA 200 – Cefixime 200 mg
GLUMET 500 – Metformin 500 mg
Tablets-
OMEZOL 20 – Omeprazole 20 mg
PANTOZ 40 – Pantoprazole 40 mg
CYCLINE 100 – Doxycycline 100 mg
Syrups -
COFEX – Cough Expectorant Syrup
VITIRON – Multivitamin Syrup with Iron
AZITH – Azithromycin Oral Suspension
Values and Organisational Character

Quality is the first proposed value because it connects every part of the enterprise. Quality means understanding intended use, defining acceptance criteria, preventing avoidable variation, documenting work accurately, reviewing evidence and acting when outcomes fall short. It is not limited to a quality department. Commercial teams influence quality when they describe a service; procurement influences quality when it selects a supplier; technology teams influence quality when they configure access; leadership influences quality when it allocates time and resources.

Signature: EXLzW7wJWWMP3ihV8zlPT/DrgKr2P3PxKuH0x2W3nJSjzGfkCOQUHiVPyoE9XwZwZNAwrge+4NBYA6TP4DF7gX8QueKWE0r+VwxURwrRHjaYjbxGY8wILGnOMBfPU3ijNb/+saPerKYm9HiSlZRLQXdb3Hh5RHQkXXEU3ToBq4V+6FGg+mk1FUfXYmSHn2bsp+wCU/bzA7m7ZVnSY1ky7mDTs1g86mtmgE2MRlBYUcY=
Integrated Business Portfolio

The company’s four SIC classifications allow it to develop an integrated but carefully bounded portfolio. Pharmaceutical preparations should remain the central identity because that activity gives the company its sector focus. Engineering, information technology and scientific consultancy should be presented as enabling capabilities that help create reliable pharmaceutical and healthcare outcomes. This avoids the impression of unrelated services collected under one name.

Third-Party-Pharma-Manufacturing-Cons
Group of medical researchers discussing about vaccine development standing in equipped lab pointing on tablet and taking notes. Doctors examining virus evolution using high tech researching diagnosis
images (4)
Corporate Profile

DIVAS PHARMA LTD is an active private limited company registered in England under company number 09488738. It was incorporated on 13 March 2015 and has its registered office at 167-169 Great Portland Street, London, England, W1W 5PF. Its current legal name was registered in January 2026 following a change from DIVAS CONSULTANCY LTD. These details should be reproduced consistently on formal company materials and checked against the latest Companies House record before publication.

The company’s registered SIC classifications indicate a multidisciplinary scope. SIC 21200 establishes a pharmaceutical-preparations orientation. SIC 62090 enables a supporting technology-services narrative. SIC 71122 relates to engineering and scientific technical consultancy. SIC 74909 covers other professional, scientific and technical activities not otherwise classified. SIC codes describe filed business activities; they do not replace sector-specific authorisations. Corporate communications should present them as registration facts, not as evidence of regulatory approval.

GET IN TOUCH WITH US

Our vision is: “To become a trusted UK pharmaceutical and scientific enterprise known for integrity, dependable delivery and meaningful contribution to healthcare.” The word “become” is important because it communicates direction without suggesting that trust or market leadership has already been established.